Kenya spends about 8% of its GDP on health. The Kenya Medical Suppliers Agency (KEMSA), a division of the Ministry of Health, largely carries out the distribution of pharmaceutical products in Kenya. It distributes drugs to government public health facilities and private health facilities. According to Fitch Solutions, spending on healthcare was valued at KES394.68bn (US$3.98bn) in 2017. Per capita healthcare expenditure reached US$80, of which as much as 61% was sourced from the private sector. In 2017, total healthcare spending accounted for around 4.8% of the country’s GDP. Kenya’s prescription pharmaceuticals market is worth over $500 million and is expected to grow at a compound annual growth rate (CAGR) of 11.8% till 2020.